About Biovie Inc
Ticker
info
BIVI
Trading on
info
NASDAQ
ISIN
info
US09074F4054
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Cuong Viet Do M.B.A.
Headquarters
info
680 West Nye Lane, Carson City, NV, United States, 89703
Employees
info
14
Website
info
https://bioviepharma.com
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease. The company develops BIV201 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.
Metrics
BasicAdvanced
Market cap
info
$20.7M
P/E ratio
info
-
EPS
info
-$3.25
Dividend Yield
info
0.00%
Beta
info
1
Forward P/E ratio
info
0
EBIDTA
info
$-23.7M
Ex dividend date
info
-
Price & volume
Market cap
info
$20.7M
Average daily volume
info
0.2M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
0.86
Earnings
EPS
info
-$3.25
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-23.7M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
1
52-week High
info
$5.61
52-week Low
info
$0.99
50-day moving average
info
$1.61
200-day moving average
info
$2.66
Short ratio
info
3.04
Short %
info
10.21%
Management effectiveness
ROE (TTM)
info
154.54%
ROA (TTM)
info
63.41%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
18.5M
Float
info
16M
Insiders %
info
13.09%
Institutions %
info
4.27%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 1 analysts.

Average price target

info
$5.50
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.22
-$0.33
33.33%
Q1 • 24Beat
-$0.80
-
-
Q2 • 24Beat
-$0.70
-
-
Q3 • 24Beat
-$0.46
-
-
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-4.2M
∞%
Q3 • 24
$0M
$-7.2M
∞%
Q4 • 24
NaN%
72.37%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$21.2M
$7.2M
33.76%
Q3 • 24
$25.7M
$1.8M
6.90%
Q4 • 24
20.98%
75.29%
79.58%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-3.6M
$0M
$-0.2M
$-3.6M
Q3 • 24
$-8.6M
$0M
$13M
$-8.6M
Q4 • 24
139.83%
-
5,481.86%
139.83%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Biovie Inc share?
Collapse

Biovie Inc shares are currently traded for undefined per share.

How many shares does Biovie Inc have?
Collapse

Biovie Inc currently has 18.5M shares.

Does Biovie Inc pay dividends?
Collapse

No, Biovie Inc doesn't pay dividends.

What is Biovie Inc 52 week high?
Collapse

Biovie Inc 52 week high is $5.61.

What is Biovie Inc 52 week low?
Collapse

Biovie Inc 52 week low is $0.99.

What is the 200-day moving average of Biovie Inc?
Collapse

Biovie Inc 200-day moving average is $2.66.

Who is Biovie Inc CEO?
Collapse

The CEO of Biovie Inc is Cuong Viet Do M.B.A..

How many employees Biovie Inc has?
Collapse

Biovie Inc has 14 employees.

What is the market cap of Biovie Inc?
Collapse

The market cap of Biovie Inc is $20.7M.

What is the P/E of Biovie Inc?
Collapse

The current P/E of Biovie Inc is null.

What is the EPS of Biovie Inc?
Collapse

The EPS of Biovie Inc is -$3.25.

What is the PEG Ratio of Biovie Inc?
Collapse

The PEG Ratio of Biovie Inc is null.

What do analysts say about Biovie Inc?
Collapse

According to the analysts Biovie Inc is considered a buy.